AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 31257453 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus MTX
Number of subjects: 0
Study 31257453 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-/reduced-dose combination therapy (ETN 50 mg or 25 mg plus MTX)
Number of subjects: 0
Study 30996038 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality Improvement Knowledge Application Tool Revised (QIKAT-R) scoring by six faculty raters (two with QI expertise, four without)
Number of subjects: 28
Study 30996038 — intervention group
Group type: EXPERIMENTAL
Intervention: Raters with QI expertise
Number of subjects: 28
Study 30996038 — intervention group
Group type: EXPERIMENTAL
Intervention: Raters without QI expertise
Number of subjects: 28
Study 30996038 — intervention group
Group type: EXPERIMENTAL
Intervention: Three raters scoring six scenarios or two raters scoring eight scenarios
Number of subjects: 28
Study 30996038 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalizability (G) study
Number of subjects: 28
Study 28166757 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared Decision Making (SDM)
Number of subjects: 24
Study 28166757 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment
Number of subjects: 24
Study 26091924 — intervention group
Group type: EXPERIMENTAL
Intervention: Four sessions of 20-30 minutes of smoking-cessation counseling
Number of subjects: 500
Study 26091924 — intervention group
Group type: COMPARATOR
Intervention: No additional counseling (Control)
Number of subjects: 500
Study 26091924 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication adherence
Number of subjects: 500
Study 23583742 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary depletion of the serotonin precursor tryptophan
Number of subjects: 19
Study 23583742 — intervention group
Group type: COMPARATOR
Intervention: Balanced placebo control diet
Number of subjects: 19
Study 20632010 — intervention group
Group type: EXPERIMENTAL
Intervention: ReSTOR +3 D
Number of subjects: 40
Study 20632010 — intervention group
Group type: COMPARATOR
Intervention: ReSTOR +4 D
Number of subjects: 40
Study 19858379 — intervention group
Group type: COMPARATOR
Intervention: GEM
Number of subjects: 533
Study 19858379 — intervention group
Group type: EXPERIMENTAL
Intervention: GEM-CAP
Number of subjects: 533
Study 17130579 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics during the first 6 months of life
Number of subjects: 200
Study 17130579 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 200
Study 15550582 — intervention group
Group type: EXPERIMENTAL
Intervention: irinotecan/5‐fluorouracil (5‐FU)/folinic acid (FA)
Number of subjects: 115
Study 15550582 — intervention group
Group type: COMPARATOR
Intervention: irinotecan/cisplatin
Number of subjects: 115
Study 11383193 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate-target displays in experiment 1
Number of subjects: 0
Study 11383193 — intervention group
Group type: EXPERIMENTAL
Intervention: Grating contrast and target luminance variations in experiment 2
Number of subjects: 0
Study 11383193 — intervention group
Group type: EXPERIMENTAL
Intervention: Common model explanation for both effects
Number of subjects: 0
Study 9422404 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus (TAC) and mycophenolate mofetil (MMF)
Number of subjects: 36
Study 9422404 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA) and mycophenolate mofetil (MMF)
Number of subjects: 36
Study 9422404 — intervention group
Group type: COMPARATOR
Intervention: Conventional CsA (Sandimmune formulation) and azathioprine (AZA)
Number of subjects: 36
Study 7795000 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-faceted treatment program for violent spouses
Number of subjects: 0
Study 2826370 — intervention group
Group type: EXPERIMENTAL
Intervention: Levamisole
Number of subjects: 64
Study 2826370 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 31199319 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacifica app for self-management of stress, anxiety, and depression
Number of subjects: 500
Study 28389218 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking training (WT), n=22, 15 bouts of 2min of walking interpolated by 2min of upright rest, twice/week for 12 weeks
Number of subjects: 42
Study 28389218 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG), n=20, 30min of stretching exercises, twice/week for 12 weeks
Number of subjects: 42
Study 25591836 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational materials (EMs)
Number of subjects: 2757
Study 25591836 — intervention group
Group type: COMPARATOR
Intervention: Standard aromatase inhibitors (AI) alone
Number of subjects: 2757
Study 23499623 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 87
Study 23499623 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete RBBB in patients with IVF
Number of subjects: 87
Study 23499623 — intervention group
Group type: COMPARATOR
Intervention: Control subjects with RBBB
Number of subjects: 87
Study 23499623 — intervention group
Group type: COMPARATOR
Intervention: Patients with IVF without RBBB
Number of subjects: 87
Study 21238543 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous upward or downward pitch rotation of the visual field at 30 and 45°/s combined with a 3 degree (30°/s) dorsiflexion tilt of the support surface
Number of subjects: 22
Study 21238543 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Principal Component Analysis (fPCA) applied to CoM trajectories
Number of subjects: 22
Study 18307371 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem 500 mg, 1000 mg, or 2000 mg every 6 or 8 hours by intravenous infusion
Number of subjects: 20
Study 18307371 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 20
Study 16566555 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxandrolone 10 mg every 12 hours
Number of subjects: 81
Study 16566555 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 12658367 — intervention group
Group type: EXPERIMENTAL
Intervention: ApoE4 genotype
Number of subjects: 2
Study 12658367 — intervention group
Group type: COMPARATOR
Intervention: Non-ApoE4 genotype
Number of subjects: 2
Study 11051370 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mU interferon TIW for 6 months + ribavirin (1000‐1200 mg daily) if HCV‐RNA positive at month 3
Number of subjects: 140
Study 11051370 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mU interferon TIW + ribavirin (1000‐1200 mg daily) for 6 months, increased to 5 mU TIW if HCV‐RNA positive at month 3
Number of subjects: 140
Study 11051370 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mU interferon TIW + ribavirin (1000‐1200 mg daily) for 6 months
Number of subjects: 140
Study 8837932 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 99
Study 1734161 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking two cigarettes of preferred brand
Number of subjects: 51
Study 1734161 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 51
Study 1734161 — intervention group
Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 51
Study 3921102 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct referral from optician to ophthalmologist
Number of subjects: 93
Study 3921102 — intervention group
Group type: COMPARATOR
Intervention: Referral through general practitioner
Number of subjects: 93
Study 29985886 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention phase (multifactorial intervention)
Number of subjects: 18900
Study 29985886 — intervention group
Group type: COMPARATOR
Intervention: Control phase (usual care)
Number of subjects: 18900
Study 29985886 — intervention group
Group type: COMPARATOR
Intervention: Training phase (intervention training)
Number of subjects: 18900
Study 26923626 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasonography (LUS)
Number of subjects: 191
Study 26923626 — intervention group
Group type: COMPARATOR
Intervention: Chest radiography (CXR)
Number of subjects: 191
Study 26923626 — intervention group
Group type: EXPERIMENTAL
Intervention: Novice physician-sonologists performing LUS
Number of subjects: 191
Study 26923626 — intervention group
Group type: EXPERIMENTAL
Intervention: Experienced physician-sonologists performing LUS
Number of subjects: 191
Study 26923626 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (LUS and CXR)
Number of subjects: 191
Study 24686046 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple Injection (TI)
Number of subjects: 96
Study 24686046 — intervention group
Group type: COMPARATOR
Intervention: Single Injection (SI)
Number of subjects: 96
Study 22610334 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil AP‐X(TM)
Number of subjects: 200
Study 22610334 — intervention group
Group type: COMPARATOR
Intervention: 3M Filtek(TM) Z350
Number of subjects: 200
Study 19890249 — intervention group
Group type: EXPERIMENTAL
Intervention: OATP1B3 polymorphism 334T>G/699G>A in patients receiving MMF with tacrolimus or sirolimus
Number of subjects: 185
Study 19890249 — intervention group
Group type: EXPERIMENTAL
Intervention: OATP1B3 334G-699A haplotype
Number of subjects: 185
Study 19890249 — intervention group
Group type: EXPERIMENTAL
Intervention: OATP1B3 variant
Number of subjects: 185
Study 17373169 — intervention group
Group type: EXPERIMENTAL
Intervention: Poly-L-lactic acid (PLLA)
Number of subjects: 65
Study 16307624 — intervention group
Group type: EXPERIMENTAL
Intervention: Notification of physicians regarding patients' limited health literacy
Number of subjects: 182
Study 11896506 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan 600 mg plus HCTZ 12.5 mg OD
Number of subjects: 309
Study 11896506 — intervention group
Group type: COMPARATOR
Intervention: Eprosartan 600 mg OD
Number of subjects: 309
Study 10459115 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 5-fluorouracil (5-FU) applied twice per day for 3 weeks
Number of subjects: 17
Study 10459115 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) using topical 5-aminolevulinic acid (5-ALA) and irradiation with a 1200 W metal halogen lamp
Number of subjects: 17
Study 10459115 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both treatments
Number of subjects: 17
Study 8590511 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.125 mg.kg-1
Number of subjects: 100
Study 8590511 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.25 mg.kg-1
Number of subjects: 100
Study 8590511 — intervention group
Group type: EXPERIMENTAL
Intervention: Edrophonium 0.50 mg.kg-1
Number of subjects: 100
Study 8590511 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Group PLAC)
Number of subjects: 100
Study 2270599 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional therapy with a free way space of greater than or equal to 1.0 mm and cuspid protected guidance
Number of subjects: 20
Study 2270599 — intervention group
Group type: COMPARATOR
Intervention: Control group (22 men)
Number of subjects: 20
Study 2270599 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional therapy
Number of subjects: 20
Study 58196 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian children with vitamin-D deficiency
Number of subjects: 500
Study 58196 — intervention group
Group type: COMPARATOR
Intervention: African, Chinese, and Scottish children
Number of subjects: 500
Study 31324360 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy with candesartan
Number of subjects: 1002
Study 31324360 — intervention group
Group type: COMPARATOR
Intervention: Antihypertensive therapy without candesartan
Number of subjects: 1002
Study 28612577 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial nail avulsion
Number of subjects: 60
Study 28612577 — intervention group
Group type: EXPERIMENTAL
Intervention: Total nail avulsion with plate replacement
Number of subjects: 60
Study 28612577 — intervention group
Group type: COMPARATOR
Intervention: Total nail avulsion (control group)
Number of subjects: 60
Study 26032797 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Message Service programme (8 weeks of monitoring/feedback)
Number of subjects: 139
Study 26032797 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 139
Study 23524061 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery Rescripting (ImRs)
Number of subjects: 10
Study 23524061 — intervention group
Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 10
Study 23524061 — intervention group
Group type: COMPARATOR
Intervention: Exploration phase (without trauma-focused treatment)
Number of subjects: 10
Study 21861997 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse order recall
Number of subjects: 0
Study 21861997 — intervention group
Group type: COMPARATOR
Intervention: Free recall
Number of subjects: 0
Study 19263337 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg/d of nonionic iron polymaltose complex + 25 IU vitamin E (as dl‐alpha‐tocopherol acetate) from 2 weeks of age
Number of subjects: 116
Study 17718920 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-circulating blankets
Number of subjects: 50
Study 17718920 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel-pads
Number of subjects: 50
Study 17718920 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravascular cooling
Number of subjects: 50
Study 17718920 — intervention group
Group type: COMPARATOR
Intervention: Conventional cooling
Number of subjects: 50
Study 17718920 — intervention group
Group type: COMPARATOR
Intervention: Air-circulating blankets
Number of subjects: 50
Study 15288371 — intervention group
Group type: EXPERIMENTAL
Intervention: FA- group (without flat affect)
Number of subjects: 24
Study 15288371 — intervention group
Group type: COMPARATOR
Intervention: FA+ group (with flat affect)
Number of subjects: 24
Study 11509799 — intervention group
Group type: EXPERIMENTAL
Intervention: Total ultrafiltration volume >2.5 kg
Number of subjects: 1238
Study 11509799 — intervention group
Group type: EXPERIMENTAL
Intervention: Total ultrafiltration volume <=2.5 kg
Number of subjects: 1238
Study 11509799 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of diabetes mellitus, older age, increased number of prescribed antihypertensive medications, lower hematocrit, absence of arrhythmias
Number of subjects: 1238
Study 11509799 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger age, increased number of prescribed antihypertensive medications, absence of arrhythmias
Number of subjects: 1238
Study 11509799 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 1238
Study 10211196 — intervention group
Group type: EXPERIMENTAL
Intervention: Video thoracoscopy
Number of subjects: 42
Study 10211196 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid thoracoscopy
Number of subjects: 42
Study 7941212 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter of information and reflection
Number of subjects: 76
Study 7941212 — intervention group
Group type: COMPARATOR
Intervention: Letter of information without reflection
Number of subjects: 76
Study 7941212 — intervention group
Group type: COMPARATOR
Intervention: No letter of information with reflection
Number of subjects: 76
Study 7941212 — intervention group
Group type: COMPARATOR
Intervention: No letter of information without reflection
Number of subjects: 76
Study 3257913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous administration of leucovorin calcium (25 mg)
Number of subjects: 37
Study 3257913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular administration of leucovorin calcium (25 mg)
Number of subjects: 37
Study 3257913 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of leucovorin calcium (25 mg)
Number of subjects: 37
Study 3257913 — intervention group
Group type: COMPARATOR
Intervention: Intravenous and intramuscular administration
Number of subjects: 37
Study 3257913 — intervention group
Group type: COMPARATOR
Intervention: All three treatments (Intravenous, Intramuscular, Oral)
Number of subjects: 37
Study 31913154 — intervention group
Group type: EXPERIMENTAL
Intervention: Early weightbearing and ankle joint mobilization exercise
Number of subjects: 69
Study 31913154 — intervention group
Group type: COMPARATOR
Intervention: Late weightbearing and ankle immobilization
Number of subjects: 69
Study 31913154 — intervention group
Group type: EXPERIMENTAL
Intervention: Late weightbearing and ankle mobilization
Number of subjects: 69
Study 31913154 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall presence of heterotopic ossification
Number of subjects: 69
Study 31913154 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterotopic ossification presence
Number of subjects: 69
Study 29214896 — intervention group
Group type: EXPERIMENTAL
Intervention: CP900 series sound processor with Hybrid Hearing
Number of subjects: 38
Study 29214896 — intervention group
Group type: EXPERIMENTAL
Intervention: CP900 with Hybrid Hearing
Number of subjects: 38
Study 29214896 — intervention group
Group type: COMPARATOR
Intervention: Freedom Hybrid sound processor
Number of subjects: 38
Study 29214896 — intervention group
Group type: COMPARATOR
Intervention: CP900 series sound processor (electric-only)
Number of subjects: 38
Study 26724816 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable wash gloves
Number of subjects: 0
Study 26724816 — intervention group
Group type: COMPARATOR
Intervention: Traditional washing methods
Number of subjects: 0
Study 23906415 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 498
Study 23906415 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 498
Study 23906415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 498
Study 23906415 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 498
Study 23564914 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraduodenal glutamine (7.5 or 15 g)
Number of subjects: 20
Study 23564914 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 20
Study 19741062 — intervention group
Group type: EXPERIMENTAL
Intervention: rt‐PA 50 mg/2 h
Number of subjects: 118
Study 19741062 — intervention group
Group type: COMPARATOR
Intervention: rt‐PA 100 mg/2 h
Number of subjects: 118
Study 19049752 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell saver group (n = 20)
Number of subjects: 40
Study 19049752 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 20)
Number of subjects: 40
Study 15897822 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined manipulative treatment, stabilizing exercises, and physician consultation
Number of subjects: 204
Study 15897822 — intervention group
Group type: COMPARATOR
Intervention: Physician consultation alone
Number of subjects: 204
Study 12898859 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body bioimpedance technique
Number of subjects: 0
Study 12898859 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental measurement from the leg
Number of subjects: 0
Study 10355243 — intervention group
Group type: EXPERIMENTAL
Intervention: To-be-combined figures that were partially occluded by irrelevant forms
Number of subjects: 0
Study 10355243 — intervention group
Group type: COMPARATOR
Intervention: Previously visible regions of the figure presented after an occluder was removed
Number of subjects: 0
Study 8522469 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole administered via feeding tube with concomitant enteral feeds
Number of subjects: 5
Study 8522469 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole administered as intravenous infusion over 1 h
Number of subjects: 5
Study 2008781 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group (received feedback on prescription errors)
Number of subjects: 20
Study 2008781 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 20
Study 7042738 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 5
Study 7042738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 30736711 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (DJ20 and DJ40) for 7 weeks
Number of subjects: 39
Study 30736711 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular soccer training)
Number of subjects: 39
Study 30736711 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (DJ20 and DJ40)
Number of subjects: 39
Study 30736711 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (DJ40)
Number of subjects: 39
Study 29278968 — intervention group
Group type: EXPERIMENTAL
Intervention: Paliperidone palmitate 1-month formulation (PP1M)
Number of subjects: 50
Study 26903532 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan cilexetil
Number of subjects: 130
Study 26903532 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 26903532 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol succinate
Number of subjects: 130
Study 25003117 — intervention group
Group type: EXPERIMENTAL
Intervention: Human amniotic membrane (HAM) covered by PU foam
Number of subjects: 45
Study 25003117 — intervention group
Group type: COMPARATOR
Intervention: Conventional polyurethane (PU) foam
Number of subjects: 45
Study 25003117 — intervention group
Group type: COMPARATOR
Intervention: PU foil/paraffin gauze
Number of subjects: 45
Study 22401676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented Exeter femoral stem
Number of subjects: 39
Study 22401676 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented Exeter femoral stem with complete circumferential cement fracture
Number of subjects: 39
Study 21048170 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 g tranexamic acid in 100 mL normal saline solution
Number of subjects: 99
Study 21048170 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g tranexamic acid in 100 mL normal saline solution
Number of subjects: 99
Study 21048170 — intervention group
Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 99
Study 17403630 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative RT-CT (radiotherapy 45 Gy on posterior pelvis + 5-fluorouracil 300 mg/m2/day for 5 days weekly during RT)
Number of subjects: 331
Study 17403630 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative RT-CT
Number of subjects: 331
Study 17403630 — intervention group
Group type: COMPARATOR
Intervention: Postoperative RT-CT
Number of subjects: 331
Study 16423743 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ms exposure duration
Number of subjects: 0